• Patient Site
  • V-Go Customer Care
vgo green
  • Call 1-866-881-1209
  • About V-Go
    • What is V-Go®?
    • Who is it For?
    • How it Works
    • Why V-Go®?
    • Authorized Distributors
  • Clinical Data
    • Optimize Delivery
    • Efficacy
    • Insulin Reduction
    • Patient Adherence
  • Prescribing & Dosing
    • Overview
  • Patient Support
    • Starting Patients
    • Comprehensive Support for You and Your Patients
    • Common Patient Questions
  • Coverage & Savings
    • Overview
  • Pharmacists
    • Overview
    • Reimbursement Card

V-Go® Resulted in Lower Insulin Requirements

The unique insulin delivery of V-Go lowered basal-bolus requirements and A1c significantly more than multiple daily injections (MDI).1

In patients who switched to V-Go from MDI, basal and bolus insulin requirements were reduced by 40% and 48%, respectively.1

Study Design: Based on a real-world, retrospective analysis of an electronic medical records database. Patients were adults diagnosed with diabetes mellitus, A1c >7.0%, and previously prescribed basal-bolus insulin therapy.

Individual results may vary.

MDI=multiple daily injections.
TDD=Total Daily Dose
*P<0.0001 compared with baseline.

Proven Effective Regardless of Patient’s Baseline Insulin Dose

Patients prescribed V-Go saw significant A1C and insulin reductions vs those on MDI.2

MDI=multiple daily injections.
*P<0.0001 compared with baseline.

View Baseline Characteristics

V-Go optimizes basal insulin delivery and supports adherence to mealtime insulin.

Study Design: Electronic medical records were queried to identify patients switched from previous insulin therapy to insulin delivery with V-Go. In all, 104 patients were stratified by moderate baseline insulin doses (<100 U/day) or high baseline insulin doses (≥100 U/day; n=38) and compared using total daily dose U/day and U/kg. A1c and average prescribed insulin dosing were collected at baseline and for 2 follow-up A1c results on V-Go (the VALIDATE study).

References: Reference: 1. Lajara R, Nikkel C. Evaluating the effect of V-Go therapy in sub-optimally controlled patients with diabetes: a retrospective cohort analysis in a large specialized diabetes system. Presented at: ISPOR. May 2017. 2. Lajara R, Nikkel C. Using V-Go wearable insulin delivery device in patients prescribed high insulin doses: a comparison of clinical results between high and moderate insulin dose groups. Poster presented at: Diabetes Technology Meeting; October 2015; Bethesda, MD.

Important Risk Information

If regular adjustments or modifications to the basal rate of insulin are required in a 24-hour period, or if the amount of insulin used at meals requires adjustments of less than 2-Unit increments, use of the V-Go Wearable Insulin Delivery Device may result in hypoglycemia. The following conditions may occur during insulin therapy with V-Go: hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose). Other adverse reactions associated with V-Go use include skin irritation from the adhesive pad or infections at the infusion site. V-Go should be removed before any magnetic resonance imaging (MRI) testing.

  • Product Specs
  • Important Safety Information
  • Contact Us
  • Zealand Pharma
  • Terms of Use & Privacy
  • Cookies
  • Site Map
  • Twitter
  • YouTube
Zealand Pharma Logo Neg (Mar2020) 316x116
White V-Go® logo
© 2021 Zealand Pharma A/S
This website uses cookies to improve your browsing experience. Read MoreAccept
Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.